For instance, nanoparticles containing RARβ agonist as a novel clinical approach for ALS treatment (Medina et al., 2020) increase lifespan and reduce neurodegeneration in SOD1G93A mice. Here, RARB is linked to amyotrophic lateral sclerosis.